Demirkilic, O. Et Al. 2024. Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes. CUREUS JOURNAL OF MEDICAL SCIENCE , no.2 .

Demirkilic, O., Eski, I., Oeztuerk, E. c., Yasun, O., AYDIN, B., BİRKAN, C., ... Oezsoy, A.(2024). Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes. CUREUS JOURNAL OF MEDICAL SCIENCE , no.2.

Demirkilic, Ozan Et Al. "Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes," CUREUS JOURNAL OF MEDICAL SCIENCE , no.2, 2024

Demirkilic, Ozan Et Al. "Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes." CUREUS JOURNAL OF MEDICAL SCIENCE , no.2, 2024

Demirkilic, O. Et Al. (2024) . "Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes." CUREUS JOURNAL OF MEDICAL SCIENCE , no.2.

@article{article, author={Ozan Demirkilic Et Al. }, title={Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, BrainDerived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes}, journal={CUREUS JOURNAL OF MEDICAL SCIENCE}, year=2024}